Aktis Oncology, Inc. (AKTS)
NASDAQ·Healthcare·Biotechnology
$23.72
+4.82%
Mkt Cap $1.17B
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (2 analysts)
$30.50
Range $30.00 – $31.00
Implied Upside
+28.6%
Consensus $30.50 vs current $23.72
NASDAQ·Healthcare·Biotechnology
$23.72
+4.82%
Mkt Cap $1.17B
Buy
2
Hold
0
Sell
0
Price Target (2 analysts)
$30.50
Range $30.00 – $31.00
+28.6%
Consensus $30.50 vs current $23.72